In comparison to individuals who did not ever take the medicines, long-standing consumers of the bone-bolstering medications called oral bisphosphonates had almost doubled the chances of developing the atypical yet lethal cancer in a lately printed trial.

These outcomes seem to disagree with what a different trial printed earlier in August stated that enrolled the analogous information of residents from the United Kingdom. That study did not uncover a considerable rise in the risk of developing esophageal cancer among those using osteoporosis medications.

Helming the recent study, Doctor Jane Green from Oxford Univ. states that additional research is necessary for determining whether intake of bisphosphonates truly does raise risk for esophageal cancer. However she added that the risk, in case any does exist, is miniscule in total terms and users of such medicines must not be worried about it.

Food and Drug Administration Raises alarm

Worries regarding the association in-between esophageal cancer and oral bisphosphonates were firstly uncovered during 2009 when the FDA reported twenty-three cancer cases among those using Fosamax or alendronate in the United States in-between 1995-2008. It also reported thirty-one cancer cases in those using bisphosphonates in Japanese and European residents.

Boniva, Actonel and Fosamax are orally taken bisphosphonates employed by scores of people suffering from bone thinning in the United States and globally.

Cases about inflammation in the esophageal region linked to acid reflux among end-users surfaced soon after they were introduced in the middle part of the nineties due to which consumers are notified on not taking the medicines along with meals or when they are in supine position.

The lately printed research as well as the one printed in August employed information from a national medical study registry in the United Kingdom entailing around six million individuals,

The current evaluation entailed around three thousand esophageal cancer patients, two thousand stomach cancer patients and 10600 colorectal cancer patients identified in from 1995 to a decade later.

Every cancer case was contrasted with 5 individuals not having cancer and matching done for age and gender.

Novel Study Findings

The assessment showed an almost doubled risk for cancer of the esophagus among those who used bisphosphonates for 5 or more years. However there was no rise in the cases of colorectal or stomach cancer cases.

On the basis of the study outcomes, the investigators approximate that duo cases of cancer of the esophagus can be anticipated in one thousand long-standing users of bisphosphonate over a 5 year period, in comparison to a single case in 5 years among one thousand users not taking bisphosphonates.

The current trial did a follow-up of the patients for almost two-folds as long and was also having additional statistical strength as compared to the earlier cited trial.

Researchers add that a patient who experiences problems when ingesting, chest pains or novel or aggravated heart burn following intake of the drugs must promptly seek medical advice. Also they added that physicians should take into consideration risks and gains for each patient prior to giving prescription of such medicines especially so for ones having digestion issues.

During the foremost print interview to a famed glossy, the sixty-five year old actor stated that he was treating it as a condition that can be cured. He added that he would leave no stone unturned in his battle with cancer and beat it.

He opened up to People magazine for the foremost instant following his cancer detection a fortnight back wherein a walnut-sized tumor was uncovered following biopsy. Lately he has commenced a stringent regime of therapy entailing radiotherapy 5 times per week lasting for 8 weeks alongside chemotherapy in three-weekly intervals.

Douglas admitted that it truly could knock a person out and during a special appearance in the Late Show with David Letterman, he spoke about his cancer being in the later staging.

He stated that that the treatment was intense & aimed at treating the cancer that has providentially not metastasized to other regions of the body. He optimistically spoke about the prognosis being quite favourable and presently be believes it to be eighty percent. However depending on the hospital and facilities offered the survival rates do show improvement.

Douglas confessed to smoke and drink previously that possibly were the cause of his throat cancer. The Academy award winner stated that he was aware of something being off-beam months prior to the physicians detecting any issue.

Throat Cancer Diagnosis in Trying Times

Following reports of cancer diagnosis breaking out a fortnight back, Douglas released a statement wherein he stated that he was quite hopeful and positive that he would tide over this condition. That outlook has not ebbed, according to better-half and co star Catherine Zeta Jones. She informed People magazine that he continues to handle his cancer in the same manner he does everything else in his life – in an utterly dignified and courageous manner.

The cancer detection has come in difficult times when in the initial part of 2010 his thirty-one year old son Cameron was held for possessing and dealing with drugs. He presently continues to serve a 5-year imprisonment for his follies and came to know of his dad’s cancer from another prisoner.

Just few months back Douglas’s former-wife dragged him to court claiming her ownership to half of his income from the forthcoming flick ‘Wall Street: Money Never Sleeps’ which opens to audiences in the later half of September where he dons the role of the money-spinner Gordon Gekko preaching the notorious tune ‘ Greed-is-good’.

Virtual Colonoscopy & V3D-Colon

Till present times, colonoscopy has been viewed as a lengthy, discomforting and not so convenient procedure. This down-beat image has only been contributory to eighty to eighty-five percent of the populace never undergoing colorectal cancer screening. It additionally dons a major role in colorectal cancer garnering the second slot in the listing for the principal reason for cancer-related deaths in the U.S., particularly given that the disease is ninety-one percent treatable when diagnosed in the earlier staging.

Virtual colonoscopy & V3D-Colon have the potential to transform this unconstructive image for life.

Virtual colonoscopy as a substitute to conventional colonoscopy could drastically enhance comfort levels among patients as it nullifies the bothersome requirement of inserting a longish tube down the colon.

During Virtual colonoscopy procedure, inflation of the colon is done using carbon-dioxide passed via the mini rectal tube after which pictures are captured employing Spiral CAT Colonography within seconds that yield 1mm resolution (in axial) and sub-mm resolution (plane paths) with lucid contrasting in-between lumen & colonic wall. Highly developed image segmentation produces a clear three dimensional re-construction and CG facilitates easier navigating via it.

V3D is available in ready-to-use turn-key Virtual Colonoscopy system and doesn’t need set-up or wide-ranging computer know-how necessary though the user would require training in using V3D. The V3D contains the needed software-hardware requisite for synergistic simulated identification based on provided images from Magnetic resonance imaging or CT Colonography.

Microneedles, Quantum Dot set to Dramatically Enhance Cancer Diagnosis

Scientists at the N. Carolina State Univ. have devised exceptionally small-sized microneedles which could be employed for delivering medically pertinent nano-scale dye forms known as quantum dots inside the skin – an advancement that could pave the path for novel methods of detection and treatment of an array of medical ailments like skin cancer.

Elucidating the finer points of their study, Doctor Roger Narayan who helmed it points out that they were capable of fabricating hollow-shaped, plastic microneedles employed a laser-manufactured rapid prototyping strategy that was noted to transport a quantum dots based mix employing such microneedles measuring below 1mm lengthwise. The laser based rapid-prototyping strategy facilitates creating microneedles of differing lengths and forms that would allow doctors in creating tailor-made microneedles for therapy of a particular condition.

The imaging technique in use during the research is multi-photon microscopy – might have medical applications in real time imaging of dye forms like quantum dots onto the skin and can be contributory to swifter detection of cancer types or other medical conditions.

The study results were part of a preliminary stage trial employed for determining the ideal dosage of the investigational PLX4032 medicine currently in the later phase of scientific studies. It has been created for targeting tumor cells carrying a BRAF mutation in a gene. Roche is the maker of this innovatory medicine that was part of a study which appeared in the ‘New England Journal of Medicine’.

During the trial, the drug use translated to total reduction of the tumors in duo patients whereas in twenty-four other patients, there was over thirty percent tumor shrinkage.

The study group pointed out that in eighty-one percent of the thirty-two patients having the BRAF mutation there was total or part shrivelling of tumors.

Elucidating their work in detail during a telephonic interview, Doctor Keith Flaherty from the Massachusetts General Hospital, Boston stated that following therapy commencement they have noted a rapid betterment in the condition of these patients noted in merely 1-2 weeks.

Doctor Flaherty points out that among asymptomatic patients, they are hopeful that the drug could postpone the time it took for the symptoms becoming apparent which they consider is occurring whilst they are discussing about it.

However the effects seem to be short-lived.

Doctor Flaherty stated that among all except for the duo cases wherein the cancer did not appear for no less than a year’s time, the gains have been transitory, classically noted to last for around 6 months.

He further added that they are endeavouring to merge PLX4032 alongside other therapies for producing a lasting impact equivalent to the AIDS combination that helps in maintaining health of HIV infected patients.

Initial outcomes with the novel medication were cited during the later part of 2009 however the information from additional patients has been included to boost confidence levels.

Tumor shrivels in all locations where the tumor had metastasized, inclusive of the liver, bones and intestines.

Cancer-causative BRAF mutations occurred in fifty to sixty percent of the melanoma cases.

PLX4032 Plus Ipilimumab – How Effective is this cocktail?

Investigators are keen on testing PLX4032 drug alongside investigative medication ‘ipilimumab’ – the foremost therapy noted to prolong lifespan among patients having advanced melanoma.

During June, investigators have cited over twenty percent of the advanced melanoma cases survived 2 years following ipilimumab therapy than the regular 9 months.

Ipilimumab (ipi) by ‘Bristol-Myers Squibb’, a modified form of a human protein which has been found to target a CTLA-4 molecule noted to operate as a braking mechanism on the immune system.

The information furnished by Doctor Flaherty and associates is representative of a noteworthy advancement in the therapy of metastasized melanoma. Associated side-effects include rashes, weariness, joint ache and an elevated risk for a diverse skin cancer form called cutaneous squamous cell carcinoma.

From the eighty-seven patients signed up in duo stages, eighteen of them developed these tumors that are simpler in treating.

The BRAF mutation is additionally noted in around eight percent of solid tumor types indicating that the medication could be effectual in other cancer types.

Melanoma is a highly belligerent type of skin cancer afflicting 160000 individuals across the globe annually. Once melanoma has metastasized, conventionally done chemotherapy is generally effectual in merely ten to twenty percent of the cases.

For meeting the burgeoning customer demands, scientists in the area of traditional medicine are working to corroborate the efficiency of primordial medications employing Western styled animal tests as well as human scientific studies.

According to a paper printed in ‘Science Translational Medicine’ the investigators stated that the cancer-afflicted rodents were given the Chinese concoct following chemotherapy session employing irinotecan which has established toxic effects on the intestines and causal to loose bowels.

Study researchers pointed out that when cancer-ridden rodents were administered chemotherapy it caused tumor shrinkage however additionally was contributory to substantial damage to the gut lining in animals.

Following just days post-treatment that involved usage of PHY906 medication, there was noteworthy restoration of damage caused to the gut lining among the rodents.

PHY906 is a lab formula which is a 1800 years old Chinese formulation that contains a purplish bloom known as skullcap, peonies, buckthorn tree produce and licorice. Known as Huang Qin Tang, the formulation has since long been deployed for treating puking, queasiness and loose bowels.

Elucidating their study, lead author, Yung-Chi Cheng spoke about how Irinotecan single-handedly diminished tumor development however when it is coalesced with PHY906 it could additionally lower tumor development.

On its own, PHY906 does not lessen tumor development and has to be employed in merger with chemotherapy.

Colorectal cancer garners the third position as the most lethal form of cancer following lung and stomach cancers and causal to 6399000 fatalities worldwide during 2004, as per information provided by the WHO.

As per data furnished by the ACS (American Cancer Society), the monetary burden arising due to colorectal cancer in regards to untimely fatality and disablement is ninety-nine billion dollars yearly, barring direct therapy expenses.

Cheng further added that their research group has since concluded a small-scaled scientific study employing the brew on seventeen colorectal cancer patients. The outcomes of the phase I, II scientific study has shown promise and the investigators would now proceed to large-scaled scientific trial.

Cheng is a stake-owner in the firm PhytoCeutica that is involved in the development of conventional Chinese medicine into cancer therapy drugs and is a PHY906 license-holder.

However a global research group helmed by LICR scientists at the Univ. of California, San Diego School of Medicine have reported in the mid-Aug edition of ‘Genes & Development’ that they have uncovered a novel signalling path in-between the GBM cells which in case finally obstructed or hampered can considerably slacken or lower tumor development and malignance.

GBMs surpass several cancerous forms in the varied groupings of cell sub-forms which feature vast heritable disparity. Cancer combatant treatments which are created for targeting a particular mutation or cellular path have a tendency of being lesser effectual while tackling heterogeneous state of tumor.

Doctor Frank Furnari, associate study researcher stated that innumerable heritable modifications might be one of the chief reasons for GBM’s lethality. Despite utmost therapy endeavours, the average survival rate in GBM cases identified is between 9 months to a year – a figure that has failed to change significantly since tens of years.

But, Furnari, an associate Prof. of medicine from the UCSD School of Medicine along with post-graduate fellow researchers observed that among GBMs merely a marginal number of tumor cells have a mutant type of the EGFR gene. Such cells impel the tumor’s swift, lethal development. Majority of the GBM’s tumor cells have a tendency of expressing wild-form or regular EGFR, still during self-expression, wild-form EGFR is a pitiable oncogene.

The researchers uncovered that cancerous cells having mutant EGFR (epidermal growth factor receptor) secreted molecules which caused adjoining cells having wild-form EGFR to hasten their cancerous development. Furnari pointed out that these mutant cells were actually giving instructions to other lesser malignant tumor cells in turning more cancerous.

Furnari stated that this signalling path present in-between GBM tumor cells was unidentified and does present a novel and rather hopeful link in the shield of glioblastomas. He added that in case cell communication could be inhibited or blocked then tumor growth could be slackened and thus might be better treated. Investigators have discovered duo molecules which seem to be triggering EGFR activity in mutant-free tumor cells.

The outcomes might additionally offer hints in the larger picture of the manner in which GBMs and other cancer types manage survival and flourish. Furnari mentioned that since long brain tumor studies have laid emphasis on the most lushly expressed mutations; however this study indicates that minor mutations also don a vital part.

Researchers point out that since ovarian cancer is a condition that has comparatively low pervasiveness hence it is vital that tests done for it must be quite precise. Hence, they deem that the test they have developed would be able to do this with ease.

The measurement stage in the test involves using one blood serum droplet following vaporization with searing helium plasma. Once the serum molecules develop electrical charge, a mass spectrometer is employed for measuring their comparative profusion. The test examines tiny molecules entailed in metabolism which are present in the serum called metabolites. Machine learning methods were then employed for sorting the groups of metabolites which were noted in the malignant plasma from those noted in normal non-cancerous samples. Mapping of the outcomes were then done in-between the metabolites observed in duo tissue sets to uncover the true meaning of such metabolic variations.

The test check did quite fine in preliminary tests that involved ninety-four entrants. Alongside being capable of generating outcomes with the use of merely a single blood serum droplet, the test was proven to be hundred per cent precise in differentiating sera in females having ovarian cancer from placebos. Additionally, the test recorded no false positives or negatives.

The study team is currently busy carrying out the subsequent group of test checks which would now entail five hundred patients.

Ovarian cancer which has less pervasiveness additionally does not show symptoms in the initial staging. Hence, in case additional tests corroborate the test’s capability of precisely detecting ovarian cancer by evaluating metabolites in serum of females, clinicians would then be able to easily spot ovarian cancer earlier on which would help saving scores of lives.

In case one is mulling over enrolling – the procedure is quite uncomplicated, however needs serious pledge. Bone marrow donation is moderately pain-free, converse to what is widely believed. And in case the transplant is successful, the outcomes are astounding.

A miniscule quantity of bone marrow donation – around five percent of the donor’s entire number – could not just refill disease-ridden supply of leukemia patients but the contributed cells additionally are capable of seeking out and obliterating any remnant cancerous cells and then continue developing, transforming the receiver’s blood type to that of the donor’s for the remaining part of his/her existence.

But, there needs to be a nearest genetic matching in-between donors and recipients, on the basis of the determining factor – HLAs or human leukocyte antigens that mirror section of the immune system being passed down through generations. A patient’s brother or sister has a twenty-five percent greater likelihood of being a well-matched donor. In around seventy percent of the cases, there are none in the kin that are compatible donors; hence a patient and his/her physician have then to seek assistance from major global registries hoping to locate a match. The ‘Be the Match’ registry is the biggest in the United States having over eight million sample types. It could also link to several registries in the United States and abroad for an entirety of almost fifteen million probabilities.

In patient types with antecedents being Caucasians hailing from N. Europe, Japan and other regions that remained cognate for generation, the likelihood of unearthing a near heritable match is over ninety percent. It is just around sixty percent for patient populace having forebears that are from Africa, Latin America or S. Asia as such sets are far more diverse.

The chances are protracted for individuals from assorted ethnic backgrounds. Hence, such global registries require individuals from all races and mixes for joining up with them.

Enrolling in a Registry

For signing up in a registry merely cheek swabs and a basic health survey is necessary. The donor has to be between eighteen to fifty-five years of age and not suffering from cancer, cardiovascular ailment, epilepsy, AIDS, hepatitis or other ailments. There are several associations which conduct bone marrow drives or have locally placed donor centers. Optionally, one could ask for kits online at ‘marrow.org’. No sooner has one enrolled in a registry, one is bound to it till one reaches sixty-one years of age or requested to be taken off.

In case cells of the person match with that of the patient, then he/she would be requested to go through additionally testing for assessing his/her health and compatible nature. The donor would not have to bear any costs and even those which are travel-related are re-payed; however the testing and donating could take time.

Nowadays, around seventy percent of bone marrow transplants do not necessitate real bone marrow. The blood collected from donors are passed via a piece of equipment where it circulates and sieves out marrow-manufacturing cells known as PBSC (peripheral blood stem cells) then the remnant blood is then infused back to the donors. Some degree of lightheaded feeling is experienced when blood is withdrawn for the stem cells. Every PBSC donor is administered shots of a protein that helps in stimulating marrow-development every day for 5 days prior to extracting it that leads to flu-similar symptoms.

There is 12-month privacy time period wherein a donor and recipient are not notified much regarding each other. However beyond that time frame, it is up to both sides whether they intend to get in touch with one another.

In case recipients need conventional bone marrow then the donors are administered general/local anesthesia after which needles are introduced inside the pelvic bone of the donors in numerous spots for extracting liquid-similar marrow within. The method would last around 2 hours. The donors could be discharged the analogous day from the facility and might sense some soreness in the tail bone region for some days.

Many times donors at the last minute change their minds on undergoing the method hence all donor registries request all who enrol to keep them informed about any modifications in their accessibility, health or location so that they could be tracked easily. Often registries that make the call are in dire need for patients who might have merely a couple of weeks to survive.

In the recent past, umbilical cord blood has become yet another medium of bone marrow transplant. Umbilical cords of newly born infants are classically thrown away as medical wastes.

Merely duo tablespoonfuls of umbilical cord blood has around a billion stem cells that have such versatility that they could be employed for creating bone marrow and  treat any array of cancers and ailments. Also they do not need a near matching in-between donors and recipients.

Donation of a newly born baby’s umbilical cord has no impact on maternal-fetal health or the birthing process, however it does need some advance preparation, as the cord preservation soon following its clamping and cutting is a must.

The procedure is au-gratis in case the birthing process is in a hospital that is part of a civic cord-blood program. In case not, parents could still do the donation though bearing some expenses, for instance, several gynaecologists would be charging 150 dollars to do the method.

All donation to public banks are unidentified and one would not know whether or when one’s infant’s cord blood is being utilized.

Parents could opt for preserving their newly born baby’s cord blood in private banks in case the child or other kin members might need bone marrow cell transplantation or some life-rescuing therapy in future. The preliminary costing for preserving cord blood is around two thousand dollars and two hundred dollars for storing it.

Around forty-three thousand individuals in the United States are identified with tumor presence in the oral, pharyngeal and laryngeal regions of the body on a yearly basis. The key risk factor associated with these types of cancers is smoking; however a current surge in such cancer cases have shown links with HPV (human papillomavirus). Majority of the cases are not detected till the cancer has progressed to a later staging.

One of the UC Davis study researchers, Prof. of biomedical engineering, Laura Marcu states that there is a comparatively greater awareness about cancers afflicting the prostate, brain and breasts as compared to oral cancer. Prof. Marcu further added that individuals do not consider looking for oral cancer and there are no regular screenings for it.

Prof. Marcu’s lab has partnered along with Doctor Gregory Farwell’s team at the Dept. Of Otolaryngology, UC Davis Cancer Center for creating the fiber optic fluorescent laser probe.

The probe is capable of stimulating molecular presence in the tissues of patients employed laser. Several of such molecular substances innately show response by re-emanating fluorescence light. The piece of equipment could swiftly spot and analyze such a light employing a process known as ‘TR-LIFS’ or time-resolved fluorescence spectroscopy that offers data regarding the kinds of molecules existing there.

At the time of surgical procedure, blood could deform the strength of fluorescent signal however not its period. When receptive measurements of the alteration in fluorescence over a period of time are used, a surgeon could view the tumor borders during the analogous instant when they are incising the tissue.

On the basis of favourable study outcomes on animal models, Prof. Marcu and Doctor Farwell’s group enlisted 9 human study entrants from amongst patients who had come to UC Davis for surgery procedure as part of their treatment on the oral, throat and laryngeal area. The duo teams contrasted spectroscopy reading outcomes with those samples that had been biopsied from the analogous sites and noted that the fiber optic probe was able to precisely detect the cancer in operative surroundings.

The probe was analogous to the one which Prof. Marcu had earlier created for use on brain tumor. During scientific studies, surgeons have employed Marcu’s technology for delineating the tumor edges at the time of surgery.

Outcomes of the human-based oral cancer research are due to appear in the forthcoming edition of the medical journal ‘Otolaryngology – Head and Neck Surgery’.

The study shows that the sooner sunbed usage is started, higher is the risk of getting a fatal melanoma prior to the age of forty.

This has shown that those people who commenced prior to turning twenty have an eighty-eight percent greater likelihood of being detected with a mortal melanoma as compared to individuals never having opted for sunbeds.

The study – foremost of its type for looking into sunbed use and skin cancer diagnosis at younger age is bound to adjoin additional bearing to the mounting campaigns for a complete prohibition on sunbed use.

The research indicates that individuals up to twenty-five years of age might have greater sensitiveness to the perils of ultraviolet radiation that are given off from sunbeds at far greater amounts than what is present in innate day light.

From the number of people who used sunbeds and are identified with skin cancer in the age group of eighteen and twenty-nine years old, around seventy-six percent of them had a likelihood of developing the disease as a direct outcome of opting for ultraviolet booths.

However in case of those people who were detected around a decade later, till the age of thirty-nine years old, merely thirteen percent of the cases might be attributable to sunbed usage.

Skin cancer specialist Doctor Conal Perrett points out that the point here is undeniable. Dr. Perrett at the Cadogan Clinic, London further added that study investigators have found that sunbed usage is linked with an augmented risk of early-inception melanoma, the highly risky form of skin cancer. The risk augments in proportion to an earlier age of foremost usage. Regrettably, large numbers of youngsters continually opt for sunbeds without totally comprehending the true risks involved.

The research was carried out by investigators from the Univ. of Melbourne involving over six hundred individuals that had been identified with skin cancer in-between the age bracket from eighteen and thirty-nine. They observed that twenty-three percent of the people had opted for sunbeds during some stage in their lifetime and on an average had begun the use of sunbed by twenty-two years of age.

The risk of getting melanoma was noted to be around forty-one percent more among those people who used sunbeds. The risk shot up proportionately to the frequent usage of sunbeds.

In case the study entrants had opted for sunbeds prior to twenty-five years of age, skin cancer risk was sixty-four percent more in comparison to those who never used sunbeds.

The study scientists have written that their findings suggest that being exposed to ultraviolet radiation arising from sunbeds is a risk for early-inception melanoma, especially melanoma identified in the age group of eighteen and twenty-nine years old.

Speaker Ed Yong stated that even though this research is comparatively small-scaled, it indicates that a sunbed user might have a greater risk of getting melanoma prior to forty years of age and also later on in his/her life.